| Literature DB >> 25799327 |
Jiandong Hu1, Ruipeng Chen2, Shun Wang2, Tingting Wang2, Yuanyuan Zhao3, Jianwei Li2, Xinran Hu4, Hao Liang5, Juanhua Zhu2, Xiaohui Sun2, Liuzheng Ma2, Min Jiang6.
Abstract
A surface plasmon resonance (SPR) immunoassay with an immobilization of self-assembled molecular identification membrane for the detection of residual Clenbuterol Hydrochloride (CLB) in pork liver was systematically investigated and experimentally validated for its high performance. SPR immunoassay with a regular competitive inhibition assay cannot be directly verified to detect CLB residuals. In this study, the binding of Au film with mercaptopropionic acid was investigated using the known form of the strong S-Au covalent bonds formed by the chemical radical of the mercaptopropionic acid and the Au film. After that, the immunoglobulin IgG of swine (SwIgG-CLB) was bonded with the mercaptopropionic acid by covalent -CO-NH- amide bonding. The modified comprehensive analysis of how the membrane structure works was introduced together with the customized SPR bioanalyzer. In order to evaluate the performance of this biomembrane structure, the concentrations of CLB-contained solutions of 0 ng · mL(-1), 10 ng · mL(-1), 20 ng · mL(-1), 33.3 ng · mL(-1), and 40 ng · mL(-1) were prepared by adding CLB reagents into the solutions of CLB antibody (Clenbuterol Hydrochloride Antibody, CLB-Ab), successively and then the response unit (RU) was measured individually. Using the data collected from the linear CCD array, the fitting curve was established with the R-Square value of 0.9929. Correspondingly, the recovery rate ranged from 88.48% to 103.21% was experimented and the limit of detection of CLB in 1.26 ng · mL(-1) was obtained efficiently. It was concluded that the detection method associated with biomembrane properties is expected to contribute much to the determination of residual CLB in pork liver quantitatively by using the customized SPR bioanalyzer.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25799327 PMCID: PMC4370770 DOI: 10.1371/journal.pone.0122005
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1The schematic diagram of the customized SPR biosensing system for the detection of CLB including the clamp for holding the microfluidic cell, the SPR biosensor, the specific support frame and the circuit board for data acquisition.
Fig 2The structure of the biomolecular recognition membrane for the detection of CLB.
Fig 3The Response Unit obtained from the functionalization of biomolecular recognition membrane.
A: Obtain the baseline by injecting the PBS through the microfluidic cell; B: Form the self-assembled monolayer (SAM) by injecting MPA; C: Activate the carboxyl groups of the self-assembled monolayer by the mixture of EDC/NHS; D: Wash away the unbound SwIgG-CLB by PBS; E: Seal off the carboxyl using Eth.
Fig 4Sensorgram for CLB-Ab binding to the immobilized SwIgG-CLB surface.
The known concentrations of CLB in sample solution are shown at the right of each sensorgram, indicating with a, b, c, d, e corresponding to the concentrations of 0 ng·mL-1, 10 ng·mL-1, 20 ng·mL-1, 33.3 ng·mL-1 and 40 ng·mL-1, respectively.
Fig 5The fitting curve of the delta Response Units with different standard CLB concentrations.
Fig 6Sensorgram of the known concentration 33.3 ng·mL-1 of the CLB sample solution with five repeated measurements.
Measurement results of the recovery rate
| Number of Measurements | Before added CLBΔRU1
| After added CLBΔRU2
| ΔRU = (ΔRU1-ΔRU2) | The actual concentration, ng/mL | The calculatedconcentration, ng/mL | Recovery rate,% |
|---|---|---|---|---|---|---|
| 1 | 180 | 108 | 72 | 33.33 | 29.49 | 88.48 |
| 2 | 165 | 102 | 63 | 33.33 | 31.82 | 95.47 |
| 3 | 151 | 98 | 53 | 33.33 | 34.40 | 103.21 |
| 4 | 158 | 104 | 54 | 33.33 | 34.14 | 102.43 |
| Average | 163.5 | 103 | 60.5 | 33.33 | 32.46 | 97.40 |
1The ΔRU1 is the ΔRU of the prepared sample solution before added the actual concentration of CLB.
2The ΔRU2 is the ΔRU of the prepared sample solution after added the actual concentration of CLB.